AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - MajorSector: Health Care
Stock price data as of 12/23/2022
Closing price: 163.10
Support price level: | $154.18 |
Resistance price level: | N/A |
Relative strength index (14-day RSI) | 47.6 |
Beta | 0.52 |
- With a 22.5 percent return in the past year, this stock outperformed 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
Low | High | Price as % of Range |
$131.98 | $174.96 | 75.1% |
200 day | 50 day | 20 day | 10 day |
$150.25 | $154.90 | $162.72 | $162.92 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
27.7% | 23.3% | 22.7% | 26.6% |
- 6.2% in the next week.
- 15.1% in the next month.
- 41.9% in the next year.
Company news for AbbVie Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks